NASDAQ : GRDX
GridAI Technologies Corp. — Company profile
Healthcare · Biotechnology · United Kingdom
Last price 4.97 USD (Oct 30, 2026, 3:13 PM EDT) · Market cap 35.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Details
| Name | GridAI Technologies Corp. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2 |
| Ceo | Jason David Sawyer |
| Country | United Kingdom |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| Isin | US33749P5070 |
| Cusip | 33749P507 |
| Cik | 0001604191 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Marshall Chapin | Chief Executive Officer of GridAI, Inc |
| Anna Skowron | Interim Chief Financial Officer |
Contact
| Address | 91 George St, Edinburgh, EH2 3ESL, United Kingdom |
| Website | https://www.grid-ai.com |